Custom Synthesis & CMO Services: Scaling Fine Chemicals and APIs from Lab to 6,300L Commercial Batches
 

At Zhejiang Haizhou Pharmaceutical Co., Ltd. (Established 1970), we support global pharmaceutical and fine chemical companies with custom synthesis, process optimization, and scalable cGMP/non-GMP contract manufacturing.

 

Operating from our production base in Zhejiang, China, we bridge the gap between initial bench-scale routes and multi-ton commercial production. We combine flexible multi-purpose reactor trains, advanced process safety screening, and a mature global regulatory framework (US FDA, EDQM, NMPA inspections).

 

Technical Infrastructure & Operational Limits
 

Our manufacturing site utilizes multi-purpose synthesis shops equipped with stainless steel (316L), glass-lined, and Hastelloy reactors. Below are our standard verified operating windows:

Parameter

Operational Capability

Facility Details & Equipment

API Reactor Capacity

50 L to 6,300 L

Dedicated cGMP lines with closed-system drying and isolation

Intermediate Reactor Capacity

500 L to 6,300 L

High-volume glass-lined and stainless steel vessels

Operating Temperature

-80°C to +250°C

Cryo-coolers, liquid nitrogen loops, high-temperature thermal oil systems

Operating Pressure

50 Pa to 5.0 MPa (50 bar)

High-vacuum fractional distillation columns & pressure reaction vessels

Inert Gas Supply

~200 m³/h continuous

High-purity N₂ piping for purging, air-sensitive transfers, and blanketing

Manufacturing Standards

cGMP and Non-GMP

Dedicated plant segregation for regulatory and non-regulatory campaigns

In-House Quality Control

Full analytical suite

HPLC, GC, Titration, LC-MS, GC-MS, and High-Field NMR

 

Specialized Chemical Reaction Capabilities

Rather than using generic synthesis routes, our technical team regularly executes complex, hazardous, or non-standard chemical transformations, including:

Cryogenic Reactions (-80°C)

Organometallic reactions, selective lithiations, and asymmetric reductions.

High-Pressure Gas Chemistry (up to 5 MPa)

Catalytic hydrogenations, carbonylation, and high-pressure amination.

Corrosive & Thermal Reactions (up to 250°C)

High-temperature cyclizations, halogenations, and acid-catalyzed condensed chemistry.

High-Vacuum Fractional Distillation (down to 50 Pa)

Separation of thermally labile intermediates and close-boiling isomer mixtures.

 

From Tech Transfer to Commercial Execution
 

Every custom synthesis campaign undergoes rigorous engineering, thermal risk evaluation, and quality planning before entering production.

Process Safety Assessment & Route Review

Before introducing a compound to plant equipment, our lab screens the chemistry using Differential Scanning Calorimetry (DSC) and reaction calorimetry (RC1). We establish heat-accumulation profiles, gas evolution rates, and runaway reaction thresholds to ensure plant-scale safety.

Process Optimization & Solvent Recycling

We refine bench-scale procedures to increase volumetric productivity and eliminate plant bottlenecks:

  • Replacing hazardous or toxic reagents with greener, commercially viable alternatives.
  • Establishing optimal crystallizing parameters (seed addition rates, cooling curves) to control particle size distribution (PSD).
  • Designing solvent recovery loops directly into the batch process to lower raw material expenditure.

Engineering Scale-Up & Pilot Campaigns

Scale-up is managed through our intermediate-scale reactor train (50 L to 500 L). Engineers calculate mass transfer rates, agitation dynamics, heat transfer surface areas, and solid-liquid isolation behavior to prevent yield drops during full-scale transfers.

Commercial Manufacturing & Quality Release

Commercial campaigns (up to 6,300 L) run under fully traceable Master Batch Records (MBR). In-Process Controls (IPC) track conversions at every key stage, followed by thorough quality control release testing.

 

Quality Assurance & Global Regulatory Compliance

Securing international commercial filings requires full compliance transparency. Haizhou Pharma's quality management systems are designed to support target market registrations in Europe, North America, and Asia.

 
 

Regulatory Audits & Compliance

Production processes operate aligned with cGMP guidance. Our site maintains an audit history supporting inspections and documentation for the US FDA, EDQM, and NMPA.

 
 
 

System Certifications

ISO 9001:2015 (Quality) and ISO 14001:2015 (Environmental Management).

 
 
 

Filing & Regulatory Support

We provide comprehensive documentation packages, including Drug Master File (DMF) technical packages, stability data (ICH conditions), process validation reports, and full Certificates of Analysis (CoA).

 

 

Analytical Development & Quality Control Operations
 

Quality control is integrated into every step of process development and manufacturing. Our on-site analytical laboratories utilize:

HPLC & GC

Purity determination, related substance profiling, and residual solvent quantification (Headspace GC).

LC-MS & GC-MS

Impurity identification, structural elucidation, and degradant isolation.

High-Field NMR

Direct structural verification for novel intermediates and key synthetic steps.

Wet Chemistry & Physical Testing

Titrations, Karl Fischer moisture measurement, loss on drying, particle size analysis, and residue on ignition.

 

Project Governance & Data Confidentiality

Protecting customer Intellectual Property (IP) is a fundamental condition of our business.

Bilateral NDAs

Mutual non-disclosure agreements are established before sharing synthetic routes, target structures, or operational specifications.

 

Dedicated Project Management

A dedicated technical project manager serves as a single point of contact, providing weekly batch progress reports, IPC data trends, and updated production schedules.

 
Technical Information Required for Inquiry Evaluation

 

To assist our R&D and engineering teams in providing a fast, accurate technical feasibility review and cost estimate, please provide the following details:

Target Molecule

CAS number, chemical structure, molecular weight, or IUPAC name.

Material Specifications

Target purity (HPLC/GC), allowable impurity profile, particle size requirements, and physical form.

Volume & Timeline

Initial pilot volume requirement, expected annual commercial demand, and target delivery dates.

 

Technical FAQ
 

Q: What reactor sizes are available for API vs. Intermediate production?

A: API lines feature cGMP-compliant reaction volumes from 50 L to 6,300 L. Intermediate and fine chemical lines feature reactor volumes from 500 L to 6,300 L.

Q: Can Haizhou Pharma handle hazardous or highly pressure-sensitive reactions?

A: Yes. Our vessels are rated for pressure conditions up to 5 MPa (50 bar) and deep vacuum conditions down to 50 Pa, equipped with continuous inert nitrogen blanketing (~200 m³/h capacity).

Q: Do you accept tech transfers with non-optimized chemistry?

A: Yes. Our process development lab specializes in taking early-stage routes, optimizing yield, establishing process safety profiles, and adapting reaction conditions for pilot and full commercial scale.

 

Ready to evaluate your compound for scale-up?

 

Submit your technical specifications or route details to our technical team for a preliminary feasibility assessment under NDA.

[Submit Your Project] [Talk to Our Technical Team]